Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2144-2146, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2144-2146.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Biochemical Mechanism of Human Immunodeficiency
Virus Type 1 Reverse Transcriptase Resistance to Stavudine
Johan
Lennerstrand,1,*
David K.
Stammers,2 and
Brendan
A.
Larder1,*
Virco UK, Ltd, Cambridge CB4
0GA,1 and Structural Biology Division,
The Wellcome Trust Centre for Human Genetics, University of Oxford,
Oxford OX3 7BN,2 United Kingdom
Received 18 December 2000/Returned for modification 9 March
2001/Accepted 25 April 2001
We have found a close correlation between viral stavudine (d4T)
resistance and resistance to d4T-triphosphate at the human immunodeficiency virus type 1 reverse transcriptase (RT) level. RT from
site-directed mutants with 69S-XX codon insertions and/or conventional
zidovudine resistance mutations seems to be involved in an
ATP-dependent resistance mechanism analogous to pyrophosphorolysis, whereas the mechanism for RT with the Q151M or V75T mutation appears to
be independent of added ATP for reducing binding to d4T-triphosphate.
*
Corresponding author. Mailing address for Brendan A. Larder: Virco UK, Ltd, 184 Cambridge Sciences Rd., Milton Rd.,
Cambridge CB4 0GA, United Kingdom. Phone: 44 1 223 728 828. Fax: 44 1 223 728 801. E-mail: brendan.larder{at}vircolab.com. Mailing
address for Johan Lennerstrand: Division of Clinical Virology, F68,
Huddinge University Hospital, 141 86 Stockholm, Sweden. Phone: 46 8 58581304. Fax: 46 8 58581305. E-mail:
johan.lennerstrand{at}impi.ki.se.
Antimicrobial Agents and Chemotherapy, July 2001, p. 2144-2146, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2144-2146.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Covens, K., Dekeersmaeker, N., Schrooten, Y., Weber, J., Schols, D., Quinones-Mateu, M. E., Vandamme, A.-M., Van Laethem, K.
(2009). Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs. J. Clin. Microbiol.
47: 2232-2242
[Abstract]
[Full Text]
-
Basavapathruni, A., Anderson, K. S.
(2007). Reverse transcription of the HIV-1 pandemic. FASEB J.
21: 3795-3808
[Abstract]
[Full Text]
-
Lennerstrand, J., Chu, C. K., Schinazi, R. F.
(2007). Biochemical Studies on the Mechanism of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to 1-({beta}-D-Dioxolane)Thymine Triphosphate. Antimicrob. Agents Chemother.
51: 2078-2084
[Abstract]
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2006). Chain-Terminating Dinucleoside Tetraphosphates Are Substrates for DNA Polymerization by Human Immunodeficiency Virus Type 1 Reverse Transcriptase with Increased Activity against Thymidine Analogue-Resistant Mutants. Antimicrob. Agents Chemother.
50: 3607-3614
[Abstract]
[Full Text]
-
Winters, M. A., Merigan, T. C.
(2005). Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms. Antimicrob. Agents Chemother.
49: 2575-2582
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2004). Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase. J. Biol. Chem.
279: 45389-45398
[Abstract]
[Full Text]
-
Boyer, P. L., Imamichi, T., Sarafianos, S. G., Arnold, E., Hughes, S. H.
(2004). Effects of the {Delta}67 Complex of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Nucleoside Analog Excision. J. Virol.
78: 9987-9997
[Abstract]
[Full Text]
-
Matamoros, T., Franco, S., Vazquez-Alvarez, B. M., Mas, A., Martinez, M. A., Menendez-Arias, L.
(2004). Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA PRIMERS. J. Biol. Chem.
279: 24569-24577
[Abstract]
[Full Text]
-
White, K. L., Chen, J. M., Margot, N. A., Wrin, T., Petropoulos, C. J., Naeger, L. K., Swaminathan, S., Miller, M. D.
(2004). Molecular Mechanisms of Tenofovir Resistance Conferred by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing a Diserine Insertion after Residue 69 and Multiple Thymidine Analog-Associated Mutations. Antimicrob. Agents Chemother.
48: 992-1003
[Abstract]
[Full Text]
-
Meyer, P. R., Lennerstrand, J., Matsuura, S. E., Larder, B. A., Scott, W. A.
(2003). Effects of Dipeptide Insertions between Codons 69 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Primer Unblocking, Deoxynucleoside Triphosphate Inhibition, and DNA Chain Elongation. J. Virol.
77: 3871-3877
[Abstract]
[Full Text]
-
Ray, A. S., Basavapathruni, A., Anderson, K. S.
(2002). Mechanistic Studies to Understand the Progressive Development of Resistance in Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Abacavir. J. Biol. Chem.
277: 40479-40490
[Abstract]
[Full Text]
-
Shafer, R. W.
(2002). Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance. Clin. Microbiol. Rev.
15: 247-277
[Abstract]
[Full Text]